Table 3.
Xenograft models of CCA using CCA cells.
| Xenotransplantation Model | Study Findings | Study |
|---|---|---|
| Injection of 3×106 Mz-ChA-1 cells +/− GABA intratumoral injection | GABA inhibits CCA growth in vivo | Fava et al., [47] |
| Injection of 3×106 Mz-IL-6 cells | IL-6 overexpression increases CCA xenograft tumor growth | Meng et al., [53] |
| Injection of 2×106 QBC939 cells +/− magnetic nanoparticle injections | Magnetic nanoparticles inhibit CCA tumor growth | Tang et al., [61] |
| Injection of 5×106 Sk-ChA-1 cells +/− intratumoral tamoxifen injection | Intratumoral tamoxifen injections decrease CCA growth | Pawar et al., [57] |
| Injection of 5×106 Mz-ChA-1 cells +/− green tea polyphenol EGCG i.p injection | EGCG decreases CCA tumor growth and increases tumor sensitivity to gemcitabine | Lang et al., [52] |
| Injection of 5×106 Mz-ChA-1 cells expressing Il-6 | Overexpression of Il-6 increases DNMT-1 expression in CCA | Braconi et al., [45] |
| Injection of 5×106 Mz-ChA-1 cells +/− resveratrol i.p injection | Resveratrol decreases Cyp1b1 expression in CCA tumors | Frampton et al., [48] |
| Injection of 5×106 Mz-ChA-1 cells +/− intratumoral anti-NYP antibody injection | NPY decreases CCA tumor growth | DeMorrow et al., [46] |
| Injection of 2×106 QBC939 cells +/− wortmannin i.p injection or +/− AdSi-beclin intratumor injection | Treatment with an autophagy inhibitor or knockdown of beclin-1 suppressed CCA xenograft tumor growth | Hou et al., [49] |
| Injection of M139 CypA-silenced CCA cell lines | CypA silencing decreases CCA xenograft tumor growth | Obchoei et al., [55] |
| Injection of HuCCT1 cell line overexpressing miR494 | miR494 decreases CCA xenograft tumor growth | Olaru et al., [56] |
| Injection of 1,5×106 CCLP1 cells +/− miR26-a overexpression | miR-26a overexpression increases in vivo CCA tumor growth | Zhang et al., [62] |
| Injection of 2×106 HuCCT-1 cells +/− WTAP-over or siWTAP | WTAP overexpression increases CCA tumor growth in an orthotopic xenograft model; WTAP knockdown decreases CCA tumor growth | Jo et al., [51] |
| Injection of 3×106 CCLP1 cells +/− miR92a or miR-17-92 | miR-19a overexpression induces CCA tumor growth in vivo | Zhu et al., [64] |
| Injection of 1×107 QBC939 cells +/− intratumoral rapamycin/salubrinal injection | Salubrinal with rapamycin has a synergistic antitumor effect in CCA | Zhao et al., [63] |
| Injection of 1×106 EGI1 cells +/− 1×107 Lent-SOX17 intratumoral injection | SOX17 overexpression decreases CCA xenograft tumor growth | Merino-Azpitarte et al., [54] |
| Injection of 5×106 HuCCT-1 cells +/−SC-43 gavage administration | SC-43 induces apoptosis in CCA via the SHP-1/STAT3 signaling pathway | Hu et al., [50] |
| Injection of 2×106 RBE cells +/− NRP-1 depletion | NRP- 1 depletion reduces tumor growth and metastasis | Zhu et al., [65] |
| Injection of 3×106 HuCCT-1 cells +/− telmisartan i.p injection | Telmisartan inhibits tumor growth in CCA | Samukawa et al., [58] |
| Injection of 1×107 RBE cells +/− shPTHLHx | Loss of PTHLH suppresses CCA tumorigenesis | Tang et al., [60] |
| Injection of 2×106 TFK-1 or HuCCT-1 cells +/− siAFAP1-AS1 | AFAP1-AS1 is oncogenic in CCA | Shi et al., [59] |